Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Mercury Pharmaceuticals Ltd, Capital House, 85 King William Street, London EC4N 7BL, UK
Alimemazine tartrate 10mg fim-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablets. Dark blue, circular, biconvex and film coated tablet. One side of tablet is marked with AL and other side is plain. |
Each film-coated tablet contains 10mg of alimemazine tartrate.
Excipients with Known effect: Lactose 34 mg/tab.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Alimemazine |
Alimemazine has a central sedative effect, comparable to that of chlorpromazine, but largely devoid of the latter’s antiadrenaline action. It has powerful antihistamine and anti-emetic actions. Alimemazine is used to treat neurosis, depression and anxiety of different origins. It prevents and relieves allergic conditions, which cause pruritus and urticaria by blocking histamine produced by the body during an allergic reaction. Alimemazine competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding. |
| List of Excipients |
|---|
|
Cellulose microcrystalline |
Tablets are packed in blisters containing 28 tablets.
Mercury Pharmaceuticals Ltd, Capital House, 85 King William Street, London EC4N 7BL, UK
PL 12762/0534
05/01/2015
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
